Associations of sirtuins with clinicopathological parameters and prognosis in non–small cell lung cancer

References

• TorreLASiegelRLJemalALung cancer statisticsAdv Exp Med Biol201689311926667336
   PubMed Web of Science ®Google Scholar
• TravisWDPathology of lung cancerClin Chest Med201132466969222054879
   PubMed Web of Science ®Google Scholar
• ChenWZhengRZhangSZhaoPZengHZouXReport of cancer incidence and mortality in China, 2010Ann Transl Med2014276125333036
   PubMedGoogle Scholar
• PaoWGirardNNew driver mutations in non-small-cell lung cancerLancet Oncol201112217518021277552
   PubMed Web of Science ®Google Scholar
• ParkSJMoreSMurtuzaAWoodwardBDHusainHNew targets in non-small cell lung cancerHematol Oncol Clin North Am201731111312927912827
   PubMed Web of Science ®Google Scholar
• DonmezGOuteiroTFSIRT1 and SIRT2: emerging targets in neurodegenerationEMBO Mol Med20135334435223417962
   PubMed Web of Science ®Google Scholar
• InoueTHiratsukaMOsakiMOshimuraMThe molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulationCell Cycle2007691011101817457050
   PubMed Web of Science ®Google Scholar
• ImaiSArmstrongCMKaeberleinMGuarenteLTranscriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylaseNature2000403677179580010693811
   PubMed Web of Science ®Google Scholar
• LandryJSuttonATafrovSTThe silencing protein SIR2 and its homologs are NAD-dependent protein deacetylasesProc Natl Acad Sci U S A200097115807581110811920
   PubMed Web of Science ®Google Scholar
• NorthBJMarshallBLBorraMTDenuJMVerdinEThe human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylaseMol Cell200311243744412620231
   PubMed Web of Science ®Google Scholar
• TannerKGLandryJSternglanzRDenuJMSilent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-riboseProc Natl Acad Sci U S A20009726141781418211106374
   PubMed Web of Science ®Google Scholar
• HaigisMCMostoslavskyRHaigisKMSIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cellsCell2006126594195416959573
   PubMed Web of Science ®Google Scholar
• LisztGFordEKurtevMGuarenteLMouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferaseJ Biol Chem200528022213132132015795229
   PubMed Web of Science ®Google Scholar
• BarberMFMichishita-KioiEXiYSIRT7 links H3K18 deacetylation to maintenance of oncogenic transformationNature2012487740511411822722849
   PubMed Web of Science ®Google Scholar
• MichishitaEMcCordRABoxerLDCell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6Cell Cycle20098162664266619625767
   PubMed Web of Science ®Google Scholar
• KumarSLombardDBFunctions of the sirtuin deacylase SIRT5 in normal physiology and pathobiologyCrit Rev Biochem Mol Biol201853331133429637793
   PubMed Web of Science ®Google Scholar
• DuJZhouYSuXSirt5 is a NAD-dependent protein lysine demalonylase and desuccinylaseScience2011334605780680922076378
   PubMed Web of Science ®Google Scholar
• ParkJChenYTishkoffDXSIRT5-mediated lysine desuccinylation impacts diverse metabolic pathwaysMol Cell201350691993023806337
   PubMed Web of Science ®Google Scholar
• NishidaYRardinMJCarricoCSIRT5 regulates both cytosolic and mitochondrial protein malonylation with glycolysis as a major targetMol Cell201559232133226073543
   PubMed Web of Science ®Google Scholar
• TanMPengCAndersonKALysine glutarylation is a protein posttranslational modification regulated by SIRT5Cell Metab201419460561724703693
   PubMed Web of Science ®Google Scholar
• LiLShiLYangSSIRT7 is a histone desuccinylase that functionally links to chromatin compaction and genome stabilityNat Commun201671223527436229
   PubMed Web of Science ®Google Scholar
• HoutkooperRHPirinenEAuwerxJSirtuins as regulators of metabolism and healthspanNat Rev Mol Cell Biol201213422523822395773
   PubMed Web of Science ®Google Scholar
• BondaDJLeeHGCaminsAThe sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerationsLancet Neurol201110327527921349442
   PubMed Web of Science ®Google Scholar
• HallJADominyJELeeYPuigserverPThe sirtuin family’s role in aging and age-associated pathologiesJ Clin Invest2013123397397923454760
   PubMed Web of Science ®Google Scholar
• BorradaileNMPickeringJGNAD(+), sirtuins, and cardiovascular diseaseCurr Pharm Des200915111011719149606
   PubMed Web of Science ®Google Scholar
• Bosch-PreseguéLVaqueroAThe dual role of sirtuins in cancerGenes Cancer20112664866221941620
   PubMedGoogle Scholar
• YuanHSuLChenWYThe emerging and diverse roles of sirtuins in cancer: a clinical perspectiveOnco Targets Ther201361399141624133372
   PubMed Web of Science ®Google Scholar
• NohSJBaekHAParkHSExpression of SIRT1 and cortactin is associated with progression of non-small cell lung cancerPathol Res Pract2013209636537023702379
   PubMed Web of Science ®Google Scholar
• ZhangTRongNChenJSIRT1 expression is associated with the chemotherapy response and prognosis of patients with advanced NSCLCPLoS One2013811e7916224223900
   PubMed Web of Science ®Google Scholar
• GrbesaIPajaresMJMartínez-TerrobaEExpression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patientsPLoS One2015104e012467025915617
   PubMed Web of Science ®Google Scholar
• LiCWangLZhengLSIRT1 expression is associated with poor prognosis of lung adenocarcinomaOnco Targets Ther2015897798425995644
   PubMed Web of Science ®Google Scholar
• GharabaghiMADiagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancerClin Respir J201812263363827768839
   PubMed Web of Science ®Google Scholar
• LinSYPengFAssociation of SIRT1 and HMGA1 expression in non-small cell lung cancerOncol Lett201611178278826834854
   PubMed Web of Science ®Google Scholar
• WangJWangCPrognostic and predictive role of sirtuin1 expression in lung adenocarcinomaClin Lab201662101989199428164517
   PubMed Web of Science ®Google Scholar
• ChenYWangTWangWPrognostic and clinicopathological significance of SIRT1 expression in NSCLC: a meta-analysisOncotarget2017837625376254428977967
   PubMedGoogle Scholar
• LiZHuangJYuanHChenZLuoQLuSSIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradationOncotarget2016714189271893926942878
   PubMedGoogle Scholar
• YangGCFuBCZhangDYThe expression and related clinical significance of SIRT3 in non-small-cell lung cancerDis Markers201720178241953
   Web of Science ®Google Scholar
• XiongYWangMZhaoJSIRT3 is correlated with the malignancy of non-small cell lung cancerInt J Oncol201750390391028197634
   PubMed Web of Science ®Google Scholar
• LuWZuoYFengYZhangMSIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancerTumour Biol20143511106991070525070488
   PubMedGoogle Scholar
• AzumaYYokoboriTMogiASIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancerJ Surg Oncol2015112223123726180037
   PubMed Web of Science ®Google Scholar
• BaiLLinGSunLUpregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathwayOncotarget2016726403774038627777384
   PubMedGoogle Scholar
• ChenTSunZLiuFWangQRASSF1A and SIRT6 in non-small cell lung cancer: relationship with clinical outcomeOncol Lett20171455759576429204192
   PubMed Web of Science ®Google Scholar
• UhlenMOksvoldPFagerbergLTowards a knowledge-based Human Protein AtlasNat Biotechnol201028121248125021139605
   PubMed Web of Science ®Google Scholar
• LiZXieQRChenZLuSXiaWRegulation of SIRT2 levels for human non-small cell lung cancer therapyLung Cancer201382191523915912
   PubMed Web of Science ®Google Scholar
• LiLWeiYToCIntegrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impactNat Commun20145546925429762
   PubMed Web of Science ®Google Scholar
• StewartPAParapaticsKWelshEAA pilot proteogenomic study with data integration identifies MCT1 and GLUT1 as prognostic markers in lung adenocarcinomaPLoS One20151011e014216226539827
   PubMed Web of Science ®Google Scholar
• XieMLiuMHeCSSIRT1 regulates endothelial Notch signaling in lung cancerPLoS One201279e4533123028940
   PubMed Web of Science ®Google Scholar
• ZhuLChiaoCYEnzerKGStankiewiczAJFallerDVDaiYSIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27Mol Cancer Res2015131414925143434
   PubMed Web of Science ®Google Scholar
• LuJZhangMHuangZSIRT1 in B[a]P-induced lung tumorigenesisOncotarget2015629271132712926318035
   PubMedGoogle Scholar
• HuangHPanXJinHPHLPP2 downregulation contributes to lung carcinogenesis following B[a]P/B[a]PDE exposureClin Cancer Res201521163783379325977341
   PubMed Web of Science ®Google Scholar
• XuWJiangKShenMQianYPengYSIRT2 suppresses non-small cell lung cancer growth by targeting JMJD2ABiol Chem2015396892993625719312
   PubMed Web of Science ®Google Scholar
• LiHFengZWuWLiJZhangJXiaTSIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non-small cell lung cancer cells through deacetylation of NMNAT2Int J Oncol20134351420143024042441
   PubMed Web of Science ®Google Scholar
• HanZLiuLLiuYLiSSirtuin SIRT6 suppresses cell proliferation through inhibition of Twist1 expression in non-small cell lung cancerInt J Clin Exp Pathol20147847744781 eCollection 201425197348
   PubMed Web of Science ®Google Scholar
• HanLLiangXHChenLXBaoSMYanZQSIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in positive regulation of NSCLC cell migrationInt J Clin Exp Pathol201361123572365 eCollection 201324228097
   PubMed Web of Science ®Google Scholar
• ChengDZhaoLXuYK-Ras promotes the non-small lung cancer cells survival by cooperating with sirtuin 1 and p27 under ROS stimulationTumour Biol20153697221723225894374
   PubMedGoogle Scholar
• LuoJBaoYCJiXXChenBDengQFZhouSWSPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growthBiochem Biophys Res Commun2017483288088428073696
   PubMed Web of Science ®Google Scholar
• XiaoKJiangJWangWSirt3 is a tumor suppressor in lung adenocarcinoma cellsOncol Rep20133031323132823842789
   PubMed Web of Science ®Google Scholar
• XiongYWangLWangSSIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancerJ Cancer Res Clin Oncol2018144218919829103158
   PubMed Web of Science ®Google Scholar
• KimEJJuhnnYSCyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathwayJ Biol Chem2015290159604961325713071
   PubMed Web of Science ®Google Scholar